Endovascular Treatment in Aortoiliac Occlusive Disease

pp 242-245

Abstract

Background: Open surgery is the traditional treatment of aortoiliac TASC type C and D lesions. However, as morbidity and mortality rates of open surgery are not negligible, endovascular treatment has emerged as a less invasive option over the last decade.

Objective: The aim of this study is to analyze our results with endovascular treatment of these iliac lesions using the primary stenting technique.

Methods: We performed a retrospective and descriptive analysis of 32 endovascular interventions for TASC C-D lesions performed from January 2012 to October 2014 to evaluate technical success, perioperative mortality and patency.

Results: Technical success was achieved in the 32 (100%) lesions treated. Primary patency was 96.8% after a mean follow-up of 14 months. Cumulative mortality was 6.25% (2 patients) during follow-up.

Conclusions: In our experience, endovascular treatment of aortoiliac TASC type C and D lesions is a feasible and safe procedure with a high recanalization rate. Endovascular treatment of this type of lesions could be considered a valid option if these findings are confirmed in large randomized controlled trials comparing this strategy with surgery.